Cedar Mountain Advisors, LLC Organon & Co. Transaction History

Cedar Mountain Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$17.45 - $21.96 $69 - $87	4 Added 200.0%	6 $0
Q1 2024 Apr 16, 2024	BUY	$13.78 - $18.8 $27 - $37	2 New	2 $0
Q3 2022 Oct 11, 2022	BUY	$23.4 - $34.25 $23 - $34	1 Added 8.33%	13 $0
Q2 2022 Jul 14, 2022	BUY	$31.66 - $38.9 $379 - $466	12 New	12 $0
Q1 2022 Apr 14, 2022	SELL	$30.45 - $39.36 $365 - $472	-12 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$28.45 - $38.0 $341 - $456	12 New	12 $0

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.